Published 4 days ago • loading... • Updated 4 days ago

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

Merck exceeded third-quarter expectations and raised profit guidance, driven by strong sales of its immunotherapy Keytruda and the newer injectable form Keytruda Qlex.

1 Articles

RocketNews

Lean Left

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

Merck exceeded third-quarter expectations and raised profit guidance, driven by strong sales of its immunotherapy Keytruda and the newer injectable form Keytruda Qlex.

4 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left1Leaning Right0Center0Last Updated4 days agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

RocketNews broke the news 4 days ago on Thursday, November 5, 2026.

Sources are mostly out of (0)

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

1 Articles

1 Articles

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Merck MASH Asset Efinopegdutide Meets Primary Goal in Mid-Stage Trial

California voters reject measure to tax the wealth of billionaires

US extends Vietnam trade probe on intellectual property by three months

Anthropic sends out, then retracts details of IPO filing, emails show: Reuters

Shapiro vows minimum wage hike, abortion protections with Pennsylvania’s Democratic trifecta

At a UN Celebration for Ted Turner, Memories of a Man Who Saw the Powe

Similar News Topics

Similar News Topics

More stories like this

Merck MASH Asset Efinopegdutide Meets Primary Goal in Mid-Stage Trial

California voters reject measure to tax the wealth of billionaires

US extends Vietnam trade probe on intellectual property by three months

Anthropic sends out, then retracts details of IPO filing, emails show: Reuters

Shapiro vows minimum wage hike, abortion protections with Pennsylvania’s Democratic trifecta

At a UN Celebration for Ted Turner, Memories of a Man Who Saw the Powe

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

1 Articles

1 Articles

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Merck MASH Asset Efinopegdutide Meets Primary Goal in Mid-Stage Trial

California voters reject measure to tax the wealth of billionaires

US extends Vietnam trade probe on intellectual property by three months

Anthropic sends out, then retracts details of IPO filing, emails show: Reuters

Shapiro vows minimum wage hike, abortion protections with Pennsylvania’s Democratic trifecta

At a UN Celebration for Ted Turner, Memories of a Man Who Saw the Powe

Similar News Topics

Similar News Topics

More stories like this

Merck MASH Asset Efinopegdutide Meets Primary Goal in Mid-Stage Trial

California voters reject measure to tax the wealth of billionaires

US extends Vietnam trade probe on intellectual property by three months

Anthropic sends out, then retracts details of IPO filing, emails show: Reuters

Shapiro vows minimum wage hike, abortion protections with Pennsylvania’s Democratic trifecta

At a UN Celebration for Ted Turner, Memories of a Man Who Saw the Powe

Bias Distribution

Factuality